These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2006-003657-24 A PHASE II MULTICENTER NON-RANDOMIZED STUDY TO ASSESS SAFETY, TOXICITY AND CLINICAL ACTIVITY OF THE ASSOCIATION OF BORTEZOMID VELCADE WITH RITUXIMAB IN RELAPSED/REFRACTORY INDOLENT NON FOLLICULAR AN... bad-data
Completed, but no date Terminated 2007-003539-22 Two repeated doses of Yttrium-90 labeled Ibritumomab-Tiuxetan (Zevalin) as salvage treatment for patients with relapsed or refractory aggressive B-cell lymphoma: a phase II study. bad-data
Ongoing 2007-003560-21 Prospective multicenter dose finding phase II pilot trial to evaluate efficacy and safety of treatment with Lenalidomide puls R-CHOP21 (LR-CHOP21) for elderly patients with untreated Diffuse Large B-C... not-yet-due